Glaucoma News and Research

Latest Glaucoma News and Research

NEI highlights new technologies and tools to help people living with low vision or blindness

During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness.

6 Feb 2017

Stem cell secretions appear to protect retinal ganglion cells in rats, study shows

A new study in rats shows that stem cell secretions, called exosomes, appear to protect cells in the retina, the light-sensitive tissue in the back of the eye.

27 Jan 2017

Researchers explore cause for increasing use of cannabis among older Americans

The U.S. Substance Abuse and Mental Health Services Administration has reported that cannabis use by persons over age 50 has outpaced recent growth observed across all other age groups.

11 Jan 2017

NIH highlights key tips and facts about glaucoma

January is Glaucoma Awareness Month. The National Eye Institute, part of NIH, is highlighting key facts about this blinding disease, important tips for prevention and treatment, and research updates you may not know about.

10 Jan 2017

Study shows new role of zinc in optic nerve injury

For more than two decades, researchers have tried to regenerate the injured optic nerve using different growth factors and/or agents that overcome natural growth inhibition.

3 Jan 2017

January is Glaucoma Awareness Month - GRF shares information about sight-stealing disease

January is National Glaucoma Awareness Month, an important time to spread the word about this sight-stealing disease.

3 Jan 2017

New imaging technique could revolutionize assessment of eye health and disease

Researchers at the University of Rochester Medical Center have developed a new imaging technique that could revolutionize how eye health and disease are assessed.

3 Jan 2017

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company announced today that it has received Health Canada approval for the TRAB 360 Trabeculotomy System.

23 Dec 2016

Researchers use worms as model system to study how gut microbiome influences disease

The billions of microorganisms living within the human digestive tract appear to play a significant role in health and disease, notably metabolic syndrome, autoimmune disorders and diabetes - but how these organisms do so is not well understood.

17 Dec 2016

New glasses may help expand sight of person with limited peripheral vision

Vision scientists may have discovered how to reduce pedestrian collisions in crowded and chaotic open space environments like bus terminals, shopping malls and city plazas involving individuals with partial blindness.

16 Dec 2016

New book provides insights into latest treatments for partial blindness

In Restoring Low Vision, renowned neuroscientist Bernhard Sabel explains cutting-edge science in language that patients can easily understand and provides a comprehensive look at the latest treatments for partial blindness.

15 Dec 2016

New contact lens therapy effective in slowing progression of juvenile-onset myopia, study shows

A groundbreaking contact lens therapy has potential to impact the fast-growing issue of myopia (nearsightedness) among children, based on research presented at the American Academy of Optometry's 95th Annual Meeting.

8 Dec 2016

Bone density could be one of early indicators of brain degeneration in Alzheimer's disease

Researchers at NEOMED have just identified a major connection between areas of the brainstem - the ancient area that controls mood, sleep and metabolism - and detrimental changes to bone in a preclinical model of Alzheimer's disease (AD).

1 Dec 2016

Zika virus can cause glaucoma in infants, report reveals

A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation.

30 Nov 2016

Allergan gets FDA approval for new XEN Glaucoma Treatment System

Allergan plc announced today the U.S. Food and Drug Administration has cleared the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) for use in the U.S.

22 Nov 2016

Noninvasive biomedical imaging technology uses light to map the brain

Scientific progress has provided a solid understanding of the anatomy of the brain. However, there is still no reliable way to examine neuron to neuron communication, as it happens--a key to understanding the correlation between brain structure and brain function.

22 Nov 2016

Researchers compare effectiveness of two treatments for glaucoma

Researchers at Queen's University Belfast together with University of St Andrews and Aberdeen have found that the procedure used to remove cataracts is more successful than current standard treatments with laser in treating Primary Angle-Closure Glaucoma - a leading cause of irreversible blindness worldwide.

17 Nov 2016

Education has greater influence on development of myopia than cognitive ability, study finds

Environmental factors such as education and leisure activities have a greater influence on the development of short-sightedness or myopia than the ability to think logically and solve problems.

16 Nov 2016

CannaCure Florida offers medical cannabis educational conference following legalization of marijuana

CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana.

14 Nov 2016

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I).

1 Nov 2016

Glaucoma News and Research

Latest Glaucoma News and Research

NEI highlights new technologies and tools to help people living with low vision or blindness

Stem cell secretions appear to protect retinal ganglion cells in rats, study shows

Researchers explore cause for increasing use of cannabis among older Americans

NIH highlights key tips and facts about glaucoma

Study shows new role of zinc in optic nerve injury

January is Glaucoma Awareness Month - GRF shares information about sight-stealing disease

New imaging technique could revolutionize assessment of eye health and disease

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

Researchers use worms as model system to study how gut microbiome influences disease

New glasses may help expand sight of person with limited peripheral vision

New book provides insights into latest treatments for partial blindness

New contact lens therapy effective in slowing progression of juvenile-onset myopia, study shows

Bone density could be one of early indicators of brain degeneration in Alzheimer's disease

Zika virus can cause glaucoma in infants, report reveals

Allergan gets FDA approval for new XEN Glaucoma Treatment System

Noninvasive biomedical imaging technology uses light to map the brain

Researchers compare effectiveness of two treatments for glaucoma

Education has greater influence on development of myopia than cognitive ability, study finds

CannaCure Florida offers medical cannabis educational conference following legalization of marijuana

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Glaucoma News and Research

Latest Glaucoma News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in